Urinary creatinine excretion, measured glomerular filtration rate and CKD outcomes. Tynkevich, Elena; Flamant, Martin; Haymann, Jean-Philippe; Metzger, Marie; Thervet, Eric; Boffa, Jean-Jacques; Vrtovsnik, François; Houillier, Pascal; Froissart, Marc; Stengel, Bénédicte; NephroTest Study Group. Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association. 2015; 1386-1394: p.1386-1394. doi:10.1093/ndt/gfv047Article
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Dowsett, M.; Forbes, J. F.; Bradley, R.; Ingle, J.; Aihara, T.; Bliss, J.; Boccardo, F.; Coates, A.; Coombes, R. C.; Cuzick, J.; Dubsky, P.; Gnant, M.; Kaufmann, M.; Kilburn, L.; Perrone, F.; Rea, D.; Thürlimann, B.; van de Velde, C.; Pan, H.; Peto, R.; Davies, C.; Gray, R.. Lancet. 2015; 1341-52: p.1341-52. doi:10.1016/S0140-6736(15)61074-1 10.1016/S0140-6736(15)61074-1. Epub 2015 Jul 23.Article
Atlas of the clinical genetics of human dilated cardiomyopathy. Haas, Jan; Frese, Karen S.; Peil, Barbara; Kloos, Wanda; Keller, Andreas; Nietsch, Rouven; Feng, Zhu; Müller, Sabine; Kayvanpour, Elham; Vogel, Britta; Sedaghat-Hamedani, Farbod; Lim, Wei-Keat; Zhao, Xiaohong; Fradkin, Dmitriy; Köhler, Doreen; Fischer, Simon; Franke, Jennifer; Marquart, Sabine; Barb, Ioana; Li, Daniel Tian; Amr, Ali; Ehlermann, Philipp; Mereles, Derliz; Weis, Tanja; Hassel, Sarah; Kremer, Andreas; King, Vanessa; Wirsz, Emil; Isnard, Richard; Komajda, Michel; Serio, Alessandra; Grasso, Maurizia; Syrris, Petros; Wicks, Eleanor; Plagnol, Vincent; Lopes, Luis; Gadgaard, Tenna; Eiskjær, Hans; Jørgensen, Mads; Garcia-Giustiniani, Diego; Ortiz-Genga, Martin; Crespo-Leiro, Maria G.; Deprez, Rondal H. Lekanne Dit; Christiaans, Imke; van Rijsingen, Ingrid A.; Wilde, Arthur A.; Waldenstrom, Anders; Bolognesi, Martino; Bellazzi, Riccardo; Mörner, Stellan; Bermejo, Justo Lorenzo; Monserrat, Lorenzo; Villard, Eric; Mogensen, Jens; Pinto, Yigal M.; Charron, Philippe; Elliott, Pe. European Heart Journal. 2015; 1123-1135a: p.1123-1135a. doi:10.1093/eurheartj/ehu301Article
Treatment de-escalation in HPV-positive oropharyngeal carcinoma: ongoing trials, critical issues and perspectives. Mirghani, H.; Amen, F.; Blanchard, P.; Moreau, F.; Guigay, J.; Hartl, D. M.; Lacau St Guily, J.. Int J Cancer. 2015; 1494-503: p.1494-503. doi:10.1002/ijc.28847 10.1002/ijc.28847. Epub 2014 Apr 4.Article
The metabolic syndrome and cancer: Is the metabolic syndrome useful for predicting cancer risk above and beyond its individual components?. Harding, J.; Sooriyakumaran, M.; Anstey, K. J.; Adams, R.; Balkau, B.; Briffa, T.; Davis, T. M. E.; Davis, W. A.; Dobson, A.; Giles, G. G.; Grant, J.; Knuiman, M.; Luszcz, M.; Mitchell, P.; Pasco, J. A.; Reid, C.; Simmons, D.; Simons, L.; Tonkin, A.; Woodward, M.; Shaw, J. E.; Magliano, D. J.. Diabetes & Metabolism. 2015; : . doi:10.1016/j.diabet.2015.04.006Article
Systematic review and meta-analysis of phase I/II targeted therapy combined with radiotherapy in patients with glioblastoma multiforme: quality of report, toxicity, and survival. dos Santos, M. A.; Pignon, J. P.; Blanchard, P.; Lefeuvre, D.; Levy, A.; Touat, M.; Louvel, G.; Dhermain, F.; Soria, J. C.; Deutsch, E.; Le Teuff, G.. J Neurooncol. 2015; 307-14: p.307-14. doi:10.1007/s11060-015-1802-5 10.1007/s11060-015-1802-5. Epub 2015 May 15.Article
How to Model Survival In Cost-Effectiveness Analysis? Differences Between Markov and Partitioned Survival Analysis Models. Minacori, R.; Bonastre, J.; Lueza, B.; Marguet, S.; Levy, P.. Value Health. 2015; A704: p.A704. doi:10.1016/j.jval.2015.09.2639 10.1016/j.jval.2015.09.2639. Epub 2015 Oct 20.Article
Propensity score matching and persistence correction to reduce bias in comparative effectiveness: the effect of cinacalcet use on all-cause mortality. Gillespie, Iain A.; Floege, Jürgen; Gioni, Ioanna; Drüeke, Tilman B.; de Francisco, Angel L.; Anker, Stefan D.; Kubo, Yumi; Wheeler, David C.; Froissart, Marc; on behalf the ARO Steering Committee collaborators. Pharmacoepidemiology and Drug Safety. 2015; 24: p.738-747. doi:10.1002/pds.3789Article
Vers une modélisation de l'incontinence urinaire de la femme. Bedretdinova, Dina. []: Université Paris-Sud; 2015. Thesis
How to switch to agomelatine after an unsuccessful try with paroxetine or venlafaxine. Lejoyeux, M.; Matharan, S.; de Bodinat, C.. CNS Spectr. 2015; 29-38: p.29-38. doi:10.1017/S1092852913000813Article